A number of research firms have changed their ratings and price targets for Sanofi SA (EPA: SAN):

  • 10/23/2017 – Sanofi SA was given a new €82.00 ($96.47) price target on by analysts at UBS AG. They now have a “neutral” rating on the stock.
  • 10/18/2017 – Sanofi SA was given a new €96.00 ($112.94) price target on by analysts at Deutsche Bank AG. They now have a “buy” rating on the stock.
  • 10/17/2017 – Sanofi SA was given a new €82.00 ($96.47) price target on by analysts at Goldman Sachs Group, Inc. (The). They now have a “neutral” rating on the stock.
  • 10/16/2017 – Sanofi SA was given a new €90.00 ($105.88) price target on by analysts at Jefferies Group LLC. They now have a “neutral” rating on the stock.
  • 10/6/2017 – Sanofi SA was given a new €92.00 ($108.24) price target on by analysts at Morgan Stanley. They now have a “buy” rating on the stock.
  • 10/6/2017 – Sanofi SA was given a new €88.00 ($103.53) price target on by analysts at Citigroup Inc.. They now have a “neutral” rating on the stock.
  • 9/18/2017 – Sanofi SA was given a new €86.00 ($101.18) price target on by analysts at Jefferies Group LLC. They now have a “neutral” rating on the stock.
  • 9/14/2017 – Sanofi SA was given a new €85.00 ($100.00) price target on by analysts at J P Morgan Chase & Co. They now have a “neutral” rating on the stock.
  • 9/12/2017 – Sanofi SA was given a new €85.00 ($100.00) price target on by analysts at BNP Paribas. They now have a “neutral” rating on the stock.
  • 9/12/2017 – Sanofi SA was given a new €81.00 ($95.29) price target on by analysts at HSBC Holdings plc. They now have a “neutral” rating on the stock.
  • 9/8/2017 – Sanofi SA had its “neutral” rating reaffirmed by analysts at J P Morgan Chase & Co. They now have a price target on the stock.
  • 9/7/2017 – Sanofi SA was given a new €90.00 ($105.88) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock.
  • 9/6/2017 – Sanofi SA was given a new €83.00 ($97.65) price target on by analysts at BNP Paribas. They now have a “neutral” rating on the stock.
  • 8/30/2017 – Sanofi SA was given a new €81.00 ($95.29) price target on by analysts at HSBC Holdings plc. They now have a “neutral” rating on the stock.

Shares of Sanofi SA (SAN) opened at 83.72 on Tuesday. The firm has a market capitalization of €105.13 billion and a PE ratio of 11.68. The company’s 50-day moving average price is €26.12 and its 200 day moving average price is €26.03. Sanofi SA has a 12-month low of €24.55 and a 12-month high of €84.58.

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company’s segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company’s pharmaceuticals operations.

Receive News & Ratings for Sanofi SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA and related companies with MarketBeat.com's FREE daily email newsletter.